Publications by authors named "Hani Elsayed"
Background And Aim: The most effective way to control severity and mortality rate of the novel coronavirus disease (COVID-19) is through sensitive diagnostic approaches and an appropriate treatment protocol. We aimed to identify the effect of adding corticosteroid and Tocilizumab to a standard treatment protocol in treating COVID-19 patients with chronic disease through hematological and lab biomarkers.
Materials And Methods: This study was performed retrospectively on 68 COVID-19 patients with chronic disease who were treated by different therapeutic protocols.
Article Synopsis
- The study investigates the impact of adding corticosteroid (Dexamethasone) and Tocilizumab to standard treatments for COVID-19 patients with chronic diseases, focusing on lab biomarkers.
- The research involved 68 patients divided into four treatment groups, with the most notable results in the group receiving both Dexamethasone and Tocilizumab, showing significant changes in white blood cell counts and C-reactive Protein levels.
- Findings suggest that the combination of Dexamethasone and Tocilizumab may enhance treatment effectiveness for chronic disease patients suffering from COVID-19.